Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
China Life Insurance A | Shanghai | Financials | Insurance | CN¥944.86B | 13.2x | 0.09 | CN¥40.60 | -0.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -5.1% Downside | Upgrade to Pro+ | |
Ping An Insurance | Shanghai | Financials | Insurance | CN¥844.22B | 7.7x | 0.72 | CN¥50.85 | -0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 18% Upside | Upgrade to Pro+ | |
People's Insurance | Shanghai | Financials | Insurance | CN¥286.44B | 4.6x | 0.09 | CN¥7.16 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -1.5% Downside | Upgrade to Pro+ | |
China Pacific Insurance | Shanghai | Financials | Insurance | CN¥281.22B | 4.9x | 0.16 | CN¥32.35 | -0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 22.1% Upside | Upgrade to Pro+ | |
New China Life Insurance | Shanghai | Financials | Insurance | CN¥122.71B | 3.6x | 14.03 | CN¥47.63 | -1.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 2% Upside | Upgrade to Pro+ | |
COFCO Capital Holdings | Shenzhen | Financials | Insurance | CN¥29.22B | 21.6x | 1.98 | CN¥12.68 | -5.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Hubei Biocause Pharmaceutical | Shenzhen | Financials | Insurance | CN¥18.72B | -24.6x | 0.08 | CN¥3.79 | -10% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Jiangxi Tianli Technology INC | Shenzhen | Financials | Insurance | CN¥4.39B | 122x | 0.3 | CN¥22.20 | -10.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |